Keenan Greg bought AUPH
February 28, 2025 · Form 4 insider transaction
Keenan Greg bought 95,570 shares of Aurinia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
95,570
Price
$0.00
Total value
N/A
InsiderKeenan Greg
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 28, 2025
Filing dateMarch 4, 2025
Shares owned after95,570
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.